TET2 and acute myeloid leukemia: Moreover, mutational and methylation studies of a large cohort of AML patients demonstrate that IDH and TET2 mutations are mutually exclusive in AML and that patients with mutation in either IDH or TET2 genes exhibit similar methylation profiles characterized by global promoter hypermethylation[47].